Humacyte Cash from Financing (TTM) Analysis

Humacyte Inc (HUMA)

3.99 +0.09 (+2.31%) USD | NASDAQ | Apr 26, 16:00

3.98 -0.01 (-0.25%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2021. Upgrade now.

Date	Value
December 31, 2023	4.507M
September 30, 2023	4.63M
June 30, 2023	5.105M
March 31, 2023	-1.394M
December 31, 2022	-1.446M

Date	Value
September 30, 2022	5.312M
June 30, 2022	247.68M
March 31, 2022	247.25M
December 31, 2021	266.98M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-1.446M

Minimum

Dec 2022

266.98M

Maximum

Dec 2021

86.51M

Average

5.105M

Median

Jun 2023

Cash from Financing (TTM) Benchmarks